Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report) insider Brian Lloyd sold 16,722 shares of the company’s stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $86.33, for a total value of $1,443,610.26. Following the completion of the sale, the insider owned 60,132 shares of the company’s stock, valued at $5,191,195.56. This trade represents a 21.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Merit Medical Systems Stock Performance
Shares of NASDAQ MMSI opened at $84.49 on Wednesday. The stock has a fifty day moving average price of $87.90 and a two-hundred day moving average price of $77.45. The company has a debt-to-equity ratio of 0.42, a quick ratio of 3.05 and a current ratio of 4.52. The firm has a market cap of $5.06 billion, a P/E ratio of 31.76, a PEG ratio of 2.10 and a beta of 0.56. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.85.
Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last issued its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.08. Merit Medical Systems had a return on equity of 14.12% and a net margin of 9.94%. The company had revenue of $416.24 million for the quarter, compared to analysts’ expectations of $410.56 million. During the same period last year, the firm earned $0.92 EPS. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. Research analysts forecast that Merit Medical Systems, Inc. will post 3.86 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on MMSI. Barrington Research set a $114.00 target price on Merit Medical Systems in a report on Friday, July 31st. Robert W. Baird set a $98.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. Freedom Capital assumed coverage on shares of Merit Medical Systems in a report on Tuesday, October 27th. They issued a “hold” rating for the company. JPMorgan Chase & Co. raised their price objective on shares of Merit Medical Systems from $95.00 to $110.00 and gave the company an “overweight” rating in a research report on Friday, October 30th. Finally, Wells Fargo & Company lifted their price objective on shares of Merit Medical Systems from $83.00 to $92.00 and gave the stock an “equal weight” rating in a research note on Friday, October 30th. Eight equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $105.91.
Get Our Latest Stock Report on MMSI
Merit Medical Systems Company Profile
Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.
See Also
- Five stocks we like better than Merit Medical Systems
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
